Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0001662579-24-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-20 | 2024-09-18 | CCCC | Adams Kendra | CFO | F - Tax | $6.38 | -1,837 | 81.8K | -2% | -$11.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-18 | F | D | 1,837 | $6.38 | 81,791 | D | — | — |